|
|
| 7:30 a.m. - 8:30 a.m. | Registration and Continental Breakfast with Exhibits |
| 8:30 a.m. - 8:45 a.m. |
Welcome and Introduction |
| 8:45 a.m. - 9:15 p.m. |
Learning Objectives:
- Examine how the 2012 national election results are likely to affect the future of the Medicare program and federal health care reforms
- Analyzes the key policy issues driving reimbursement changes for laboratory and pathology services
- Describes the top legislative and regulatory challenges for labs in the year ahead
|
| 9:15 a.m. - 9:45 a.m. | What Do Investors Know About the Evolving Lab Business Model that We Don't?
Learning Objectives:
- Discuss how systemic changes in the health care system are affecting the current lab business model
- Discuss emerging market reforms and how they will impact the clinical laboratory and pathology sectors
- Find out how labs will be transitioning from the current volume-based model to one focused on value and medical practice consultation
|
| 9:45 a.m. - 10:15 a.m. | Market Factors Driving North Shore LIJ Health System Laboratories
Learning Objectives:
- Describe key market characteristics of North Shore LIJ Health System Labs
- Assess how health care reforms and health plan initiatives are shaping the competitive climate for the health system and its laboratory
- Find out what proactive strategies North Shore LIJ Health System Labs in considering to strengthen its market viability
|
| 10:15 a.m. - 10:30 a.m. | Networking Break with ExhibitsSponsored by The ARx Group |
| 10:30 a.m. - 11:00 a.m. | Going Beyond the Numbers at Quest and LabCorp
Learning Objectives:
- Review the financial results of Quest and LabCorp
- Discuss how current market trends are shaping the performance of both companies
- Describe key developments inside Quest and LabCorp that are affecting their numbers
- Contrast the relative financial performance and outlook for both companies
|
| 11:00 a.m. - 11:30 a.m. | What the National Labs Don’t Get the About the AP Market
Learning Objectives:
- Compare the size and growth rate of the overall U.S. anatomic pathology market versus Quest and LabCorp’s growth rates
- Analyze the post-deal results of Quest’s acquisition of AmeriPath and LabCorp’s purchase of Dianon
- Understand the market challenges facing the pathology sector such as in-office labs and longer intervals for Pap testing
|
| 11:30 a.m. - 12:00 p.m. | Key Developments and Trends Impacting Lab Industry Growth and Earnings: Panel Discussion with Q&A
Learning Objectives:
- Analyze how critical policy and industry trends will affect the lab and pathology sectors
- Evaluate the performance of top lab companies and their impact on the larger market
- Respond to questions and feedback from audience participants
|
| 12:00 p.m. - 1:00 p.m. | Networking LuncheonSponsored by |
| 1:00 p.m. - 1:30 p.m. | Laboratory Specialty Testing: What Are the Growth Drivers?
Learning Objectives:
- Outline the established and emerging areas of specialty testing
- Examine the key drivers of growth for specialty testing including the rapidly growing and diversifying area of molecular diagnostics
- Review potentially “game-changing” tests and technologies as well as key market developments to watch
|
| 1:30 p.m. - 2:30 p.m. | Key Reimbursement Trends Impacting the Lab Sector
Learning Objectives:
- Discuss the logistical and financial impacts of proposed changes in Medicare reimbursement for molecular diagnostics
- Identify and understand potential strategies designed to offset the impacts of Medicare clinical lab fee schedule cuts
- Explain how one state-of-the-art pathology lab is utilizing predictive molecular studies to increase predictive power and value added to the clinical decision process in an environment of reimbursement constraints
Carlos Cordon-Cardo, M.D., Ph.D., Professor and Chairman, Department of Pathology, Professor, Department of Genetics and Genomic Sciences, The Mount Sinai School of Medicine. Professor and Director, Department of Pathology, The Mount Sinai Hospital
Pia Gargiulo, Ph.D., Senior Director, Companion Diagnostic Partnerships, QIAGEN CorporationRina Wolf, Vice President of Commercialization Strategies Consulting and Industry Affairs XIFIN, Inc.Antony Pfaffle, M.D., Director of Healthcare Research, Bearing Circle Capital, LPChair: Michael Manns, Senior Healthcare Specialist, Bloomberg Industries |
| 2:30 p.m. - 3:15 p.m. | How Private Insurers View the Laboratory Market
Learning Objectives:
- Identify the key objectives for lab contracting by health plan contract administrators
- Explain the requirements for participation in health plan administered networks
- Identify health plan goals and objectives with respect to the reduction in size and scope of their lab networks
- Examine key hurdles to obtaining value-based reimbursement for lab services
|
| 3:15 p.m. - 3:30 p.m. | Networking Break with Exhibits |
| 3:30 p.m. - 4:00 p.m. | Why It Makes Sense to Invest in the Laboratory Sector
Learning Objectives:
- Identify key market factors that contribute to a positive investment climate for the lab industry
- Assess health care industry trends that are not conducive to investing in the lab sector
- Discuss considerations of structure, ownership, management and governance for somebody acquiring or investing in an individual lab company
|
| 4:00 p.m. - 4:30 p.m. | My Favorite Lab Stock
Learning Objectives:
- Describe key financial factors that can be used in evaluating publicly traded laboratory companies
- Discuss how a lab industry perspective on emerging trends can add essential context to a strict financial analysis
- Compare how individual companies rate in applying these financial and industry indictors
- Select favorite lab company based on this analysis
|
| 4:30 p.m. - 5:00 p.m. | Lab Investment Opportunities and Outlook: Panel Discussion with Q&A
Learning Objectives:
- Assess leading reimbursement and health plan trends driving the lab investment climate
- Evaluate critical factors driving lab investment decisions
- Respond to questions and feedback by audience participants
Michael Manns, Carlos Cordon-Cardo, M.D., Ph.D., Pia Gargiulo, Ph.D., Rina Wolf, Antony Pfaffle, M.D., Michael Snyder, Todd Van Horn, David NicholsChair: Stephanie Murg |
| 5:00 p.m. | Adjournment |
| 5:00 p.m. - 6:00 p.m. | Networking Cocktail Reception
Program Subject to Change |
|
Gold Sponsor:
|